Table 1.

Studies of lenalidomide and bortezomib maintenance therapy post ASCT.

Studies of lenalidomide and bortezomib maintenance therapy post ASCT.

TTP indicates time to progression; MP indicates Melphalan prednisone; MPR indicates Melphalan prednisone revlimid; MPR-R indicates Melphalan prednisone revlimid-revlimid; and IR indicates incidence rate.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal